Liver cirrhosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Liver cirrhosis patients with hypoalbuminemia (serum albumin level <3.5g/dl) at the time of registration or past history for hypoalbuminemia 2.Patients with decompensated liver cirrhosis (with ascites, edema and/or hepatic encephalopathy at present or past history of ascites, edema and/or hepatic encephalopathy) 3.Patients aged 20 years or more
Exclusion criteria
Exclusion criteria: 1.Patients being treated with intravenous albumin preparation 2.Patients being treated with fresh frozen plasma formulation 3.Patients with stage II or more advanced HCC 4.Patients with uncontrollable HCC 5.Patients with total bilirubin >3.0 mg/dl 6.Patients with hepatic encephalopathy (hepatic coma: grade III or more) 7.Patients with congenital branched-chain amino acid related metabolic disorders 8.Patients with malignancies other than HCC 9.Patients ineligible for study as determined by research investigator or research doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Annual changes in muscle mass volume | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival Time to liver disease-related event | — |
Countries
Japan
Contacts
Hyogo College of Medicine Division of Hepatobiliary and Pancreatic Disease